Daily Market Reports | 10:30 AM
An additional news report on the recommendation, valuation, forecast and opinion changes and updates for ASX-listed equities.
In addition to The Australian Broker Call Report, which is published and updated daily (Mon-Fri), FNArena has now added The Australian Broker Call *Extra* Edition, featuring additional sources of research and insights on ASX-listed stocks, also enlarging the number of stocks that make up the FNArena universe.
One key difference is the *Extra* Edition will not be updated daily, but merely "regularly" depending on availability of suitable quality content. As such, the *Extra* Edition tries to build a bridge between daily updates via the Australian Broker Call Report and ad hoc news stories, that are not always timely for investors hungry for the next information update.
Investors using the *Extra* Edition as a source of input for their own share market research should thus take into account that information after publication may not be up to date, or yet awaiting another update by FNArena's team of journalists.
Similar to The Australian Broker Call Report, this *Extra* Edition includes concise but limited reviews of research recently published by Stockbrokers and other experts, which should be considered as information concerning likely market behaviour rather than advice on the securities mentioned. Do not act on the contents of this Report without first reading the important information included at the end of this Report.
The Australian Broker Call *Extra* Edition is a summary that has been prepared independently of the sources identified. Readers will check the full text of the recommendations and consult a Licenced Advisor before making any investment decision.
The copyright of this Report is owned by the publisher. Readers will not copy, forward or disseminate this Report to any other person. For more vital information about the sources included, see the bottom of this Report.
COMPANIES DISCUSSED IN THIS ISSUE
Click on a symbol for fast access.
The number next to the symbol represents the number of brokers covering it for this report -(if more than 1)
ALL AUB AX1 COH CPU CU6 DUG GNC IMR ING MYG OMA QAL (2) RDY SPZ TGN XRO
SPZ SMART PARKING LIMITED
Hardware & Equipment - Overnight Price: $0.65
Canaccord Genuity rates ((SPZ)) as Buy (1) -
Canaccord Genuity retains its Buy rating for Smart Parking with its target price lowered to $1.50 from $1.80 following a 1Q27 trading update at the annual general meeting showing softer near-term earnings momentum.
Quarterly revenue rose 11% year-on-year, or 15% in constant currency, to $31.4m on the back of 18% site growth and 8% parking breach notice volume growth, while adjusted EBITDA edged up 1% to $8m at a 25.5% margin.
Full-year guidance for 450 to 600 net new site additions was reaffirmed alongside progress across 40 contracted US automatic number plate recognition sites, though 1Q27 earnings were weighed down by foreign exchange headwinds, unwinding UK secondary debt recovery benefits, US sales team investments, and softer September UK notice issuance.
Factoring in more adverse foreign exchange assumptions, lower breach notices per site, and a higher discount rate, Canaccord lowers its FY27, FY28, and FY29 adjusted EBITDA estimates by -5% each to $35.5m, $43.0m, and $50.0m, respectively.
Canaccord views FY27 as a transitional year as US acquisitions integrate and European operations narrow losses, anticipating a significant FY28 earnings inflection and a compelling valuation at 5.8x FY28 EV/EBITDA versus recent private transactions at 11x to 17x.
This report was published on November 13, 2026.
Target price is $1.50 Current Price is $0.65 Difference: $0.855
If SPZ meets the Canaccord Genuity target it will return approximately 133% (excluding dividends, fees and charges).
The company's fiscal year ends in June.
Forecast for FY27:
Canaccord Genuity forecasts a full year FY27 dividend of 0.00 cents and EPS of 4.00 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 16.13.
Forecast for FY28:
Canaccord Genuity forecasts a full year FY28 dividend of 0.00 cents and EPS of 5.40 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 11.94.
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
TGN TUNGSTEN MINING NL
Tungsten - Overnight Price: $0.18
Canaccord Genuity rates ((TGN)) as Speculative Buy (1) -
Canaccord Genuity maintains a Speculative Buy rating for Tungsten Mining with a $0.45 target price following the release of a Definitive Feasibility Study for its wholly owned Watershed tungsten project in Queensland.
The study outlines an approximate 10-year mine life at 3.5m tonnes per annum throughput producing 223,400mtu annually, with pre-production capital expenditure reduced to -$264m from -$274m after removing the scheelite flotation circuit and heated cleaner stages.
While the process flow sheet revision lowers recoveries to 62.3% and requires a larger pit with a 2.5x strip ratio, processing costs fall by -56% and all-in sustaining costs sit at US$538/mtu, generating 64% margins at an updated life-of-mine realised ammonium paratungstate price of US$1,500/mtu.
Canaccord views the study as a key de-risking milestone ahead of expected near-term catalysts including binding offtake agreements, debt financing finalisation, and a final investment decision prior to year-end, with production on track before the end of the first half of 2027 and initial positive cash flow anticipated from the September quarter of 2027.
This report was published on November 16, 2026.
Target price is $0.45 Current Price is $0.18 Difference: $0.27
If TGN meets the Canaccord Genuity target it will return approximately 150% (excluding dividends, fees and charges).
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
XRO XERO LIMITED
Accountancy - Overnight Price: $80.56
Jarden rates ((XRO)) as Buy (1) -
Jarden retains a Buy rating for Xero with its target price increased to $120.00 from $117.00 following a 1H27 result underpinned by a US payments-led upgrade alongside steady growth across other core markets.
Jarden views the performance as further evidence of strategic progress, noting the US is becoming a larger growth contributor with improving product market fit and payments convergence validating the Melio acquisition.
Management now expects to reach the Rule of 40 in FY27, lifted its FY28 revenue aspiration above NZ$4.6bn excluding roughly US$70m in revenue synergies, and announced an on-market share buyback of up to NZ$1bn.
The lifted valuation reflects these forecast updates under a methodology equally weighted between 18x one-year forward EV/EBITDA and discounted cash flow.
This report was published on November 16, 2026.
Target price is $120.00 Current Price is $80.56 Difference: $39.44
If XRO meets the Jarden target it will return approximately 49% (excluding dividends, fees and charges).
Current consensus price target is $115.53, suggesting upside of 43.4%(ex-dividends)
Forecast for FY27:
Current consensus EPS estimate is 111.5, implying annual growth of N/A.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 72.3.
Forecast for FY28:
Current consensus EPS estimate is 187.9, implying annual growth of 68.5%.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 42.9.
This company reports in NZD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 0.9
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Disclaimer:
The content of this information does in no way reflect the opinions of FNArena, or of its journalists. In fact we don't have any opinion about the stock market, its value, future direction or individual shares. FNArena solely reports about what the main experts in the market note, believe and comment on. By doing so we believe we provide experienced, intelligent investors with a valuable tool that helps them in making up their own minds, reading market trends and getting a feel for what is happening beneath the surface.
This document is provided for informational purposes only. It does not constitute an offer to sell or a solicitation to buy any security or other financial instrument. FNArena employs very experienced journalists who base their work on information believed to be reliable and accurate, though no guarantee is given that the daily report is accurate or complete. Investors should contact their personal adviser before making any investment decision.
Decisions about inclusions in this Report are made independently of the providers of stock market research and at full discretion of the team of journalists responsible for content at FNArena. Inclusion does not equal endorsement, in any way, shape or form. This Report is provided for informational purposes only.
FNArena content is produced by real people. We use AI tools to assist with grammar checks, research verification and internal processes. Our experienced editorial team follows financial markets closely, identifies valuable insights from research reports and retains full responsibility for editorial decisions and published content.
The full story is for FNArena subscribers only. To read the full story plus enjoy a free two-week trial to our service SIGN UP HERE
If you already had your free trial, why not join as a paying subscriber? CLICK HERE
